Research library Handling & Storage
Laboratory handling
How Is a Lyophilized Peptide Reconstituted?
Article
Handling & Storage · 6 MIN READ · HANDLING
01 / Overview
Returning the solid to solution
A lyophilized peptide is a freeze-dried solid: the sequence, its counterions and residual water, pressed into the white cake at the bottom of the vial. Before laboratory use it is returned to solution. The procedure is short, but two details - how the solvent is introduced and how the resulting concentration is computed - account for most avoidable errors.
Introducing the solvent
Solvent should be introduced slowly, directed at the inside wall of the vial rather than at the cake. A direct jet can cause foaming, and foaming shears peptide chains at the air-liquid interface - interfacial stress is a documented driver of aggregation [1]. Once the solvent is in, the vial is swirled gently until the solution is clear; it is not shaken. Most research peptides dissolve within a few minutes. Persistent cloudiness is information - some hydrophobic or strongly basic sequences require an adjusted approach, and a supplier able to state the recommended solvent for a specific material should do so on the record for that material.
Choice of solvent
Sterile water is the default for most sequences. Some materials, GHK-Cu among them, are conventionally handled in mildly acidified water; where that applies to a specific material it belongs on the record for that material. This article does not cover solvent choices for any use in living subjects, which is outside the scope of this site.
Why does solubility differ between sequences?
Solubility follows composition. Sequences rich in charged residues - lysine, arginine, aspartate, glutamate - dissolve readily in water; sequences dominated by hydrophobic stretches resist it; and a cake that has taken up moisture or partially collapsed dissolves more slowly than an intact one. This is why dissolution behavior is itself a quality observation: a material that previously dissolved cleanly and now will not is reporting a change, either in the lot or in its storage history.
The arithmetic
Concentration is the vial content divided by the solvent volume. Ten milligrams reconstituted in two milliliters gives 5.00 mg/mL, equivalently 5000 ug/mL. The ug/mL figure is the mg/mL figure multiplied by one thousand - two units for the same quantity, both in routine use. Our concentration calculator performs exactly this arithmetic and nothing else.
Combination vials require one extra step. A vial labeled 10 mg total containing two constituents of 5 mg each, reconstituted in 2 mL, is a solution that is 5.00 mg/mL in total peptide but 2.50 mg/mL in each constituent. Calculations that concern a specific constituent must use the constituent amount, which is why FLASK combination records state each constituent's mass separately rather than only the total.
Which mass belongs in the calculation?
The label weight is the gross mass of the solid, which includes counterions and residual moisture; the peptide itself is the net peptide content, typically 70 to 90 percent of the label for commercial material [2]. For qualitative work the distinction may not matter. For molar calculations it does: a 10 mg label with 75 percent net content delivers 7.5 mg of peptide, and a concentration computed from the label overstates the solution by a third. Where the batch record reports net peptide content, that is the number the arithmetic should start from.
After reconstitution
A reconstituted solution is less stable than the lyophilized solid. As general laboratory practice, solutions are refrigerated, protected from light, and used within a limited window; the window itself is sequence-dependent, and published stability data, where it exists for a given sequence, is the reference [3]. Repeated freeze-thaw cycles degrade peptide solutions and are avoided by aliquoting.
What should be recorded at reconstitution?
Four entries make the solution reproducible and auditable later: the lot number of the vial, the date, the solvent and volume used, and the computed concentration with the mass basis noted - label weight or net content. A solution whose preparation is recorded can be compared against a later one; a solution prepared from memory cannot. The habit costs one line in a notebook.
Frequently asked questions
Why should the vial not be shaken?
Foaming shears peptide chains at the air-liquid interface. Gentle swirling until the solution is clear is sufficient.
How long does a reconstituted solution last?
The window is sequence-dependent and no single figure covers all materials. Solutions are refrigerated, protected from light and aliquoted to avoid freeze-thaw cycles.
How is concentration calculated for a blend?
Per constituent. A 10 mg vial with two 5 mg constituents in 2 mL is 5.00 mg/mL in total peptide but 2.50 mg/mL in each constituent.
Should concentration be computed from the label weight or net peptide content?
From net peptide content where the record reports it. The label weight includes counterions and moisture, so label-based arithmetic overstates the true concentration.
What does it mean if the cake will not dissolve?
It is information. Composition, moisture uptake or storage history can all slow dissolution; a material that behaves differently from its previous lots warrants a question rather than more shaking.
Key facts
- Default solvent Sterile water for most sequences; some materials such as GHK-Cu are handled in mildly acidified water
- Technique Introduce solvent slowly down the inside wall, swirl gently, do not shake
- Concentration Vial content divided by solvent volume: 10 mg in 2 mL is 5.00 mg/mL or 5000 micrograms per mL
- Mass basis Use net peptide content for molar work; the label weight includes counterions and moisture
- Combination vials Calculate using each constituent mass, not the total
Footnotes & references
References
- Liu L, Qi W, et al. The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study. J Pharm Sci. 2013;102(8). PMID: 23712900.
- Erckes V, Streuli A, et al. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Biological Assays. Pharmaceuticals (Basel). 2025;18(8). PMID: 40872554.
- Manning MC, Chou DK, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. PMID: 20143256.
Related products & records
Read the specification and the record
Use the lot record and testing pages for the source analytical documentation.
Related reading